Compares eye pressure and complications after different glaucoma surgeries
Studies how well different glaucoma surgeries lower eye pressure, including a microshunt.
Plain-language title generated from the registry record
Registry title: NorMIGS - a Study of Micro-invasive Glaucoma Surgery
Key facts
- Where
- Oslo, NorwaySee the site
Where in Norway
- Department of Ophthalmology, Oslo University HospitalOslo, NorwayTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Oslo University Hospital
- Trial code
- NCT05340647
- Record updated
- 29 November 2022
- Original description
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.Read full original descriptionShow less
NorMIGS - a Prospective Study of Micro-invasive Glaucoma Surgery
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.
Inclusion: Patients must be 18 years or older at the time of signing the informed consent form. There is no upper age limit; Scheduled for implantation of Preserflo microshunt, trabeculectomy or other types of MIGS; Ability to cooperate fairly well during the examinations; Willing to participate in the study and capable of providing informed consent.
Exclusion: High intraocular pressure due to increased episcleral venous pressure, hemorrhagic glaucoma, traumatic glaucoma or uveitis glaucoma.